MFN2 and neoplasm: Similarly, Leflunomide, an FDA-approved arthritis drug, was shown to increase Mfn2 expression and suppress tumor growth in a study of pancreatic ductal adenocarcinoma, indicating its potential repurposed used as a chemotherapeutic agent [80].